Tagged with Medtech,

Colombia J&J Medical Devices regional VP Mircea Cubillos discusses the long-term vision for J&J in Colombia and Latin America. Moreover, he speaks about the company’s strategy for emerging markets, the importance of the collaboration with stakeholders and government actors in the medical devices sector, as well as his personal motivation to…

Taiwan Ken-Shwo Dai, president and CEO of Visgeneer, explains his biotech’s expertise in medtech, skincare, gene therapy and diagnostics, as well as his plans to take the company public. Can you introduce yourself and Visgeneer to our readers? What have been the main milestones for the company so far? “Visgeneer believes that…

Colombia Regional leader of Boston Scientific’s Andean Region, Fernando Dussan, share his insights on why Colombia is suitable to host the core business of Boston Scientific. He speaks about the company’s expansive portfolio, the key challenges in the ecosystem, as well as building a holistic partnership that places the patients at…

Mexico An ambassador for Philips’ global vision of spearheading innovation, business leader of Philips Personal Health Mexico, Eduardo Gutierrez, shares his insights on the key growth drivers in the segment, digitalization, connectivity, and his personal motivations in the role. To begin, can you introduce the main facets of your role at…

Taiwan Philips Healthcare Taiwan general manager, Jan Poon, talks about the innovative approach that Philips aims to implement in the local market; spanning from establishing a digital platform to working with government when ensuring the sustainability of Taiwan’s healthcare system. You have recently become GM for Philips Taiwan. What have been…

Mexico Mexico’s medical device segment displays promising growth indicators, with innovative companies providing integrated and digital solutions now firmly embedded within the healthcare landscape. However, regulatory obstacles as well as a lack of joined-up thinking in the public sector remain in place; potentially restricting the industry from realising its full potential.…

France Bertrand Letartre of Anios discusses the company’s rich history, their move towards more technical offerings with the acquisition of Soluscope, internationalization, family values, and the company’s mission to spread awareness of the importance of hygiene in hospitals. This year Laboratoires Anios turned 118. Four generations later, the company has developed…

Switzerland The VP of Medtronic’s Benelux, Central Europe, Greece and Israel cluster highlights the global medtech giant’s efforts to position itself as the partner of choice to tackle prevailing global healthcare challenges. Medtronic is famous for the concept of “value based healthcare”. Medtronic’s global CEO Omar Ishrak recently said that it…

Greece In the price versus value discussion brought on by Greece’s economic crisis, Philips’ message is clear: they offer novel solutions that can do more for less and place the patients at the center. Philips Hellas’ Managing Director, Panagiotis Mparas, speaks about the company’s healthcare footprint in Greece; reconciling the corporate…

Mexico By his own admission. Metrohm CEO Jodok Reinhardt has a dream job. He reveals how the company has become a successful and slightly different outfit when it comes to supplying the very latest chemical analysis instruments. Metrohm has grown from a start-up in the 1940s to one of the most…

Mexico José Antonio Garcia, CEO of Vensi, describes how the company’s unique service model is redefining how healthcare institutions approach the purchasing of medical equipment, while detailing the strategic significance of the recently award IMSS contract in validating their business model and augmenting future business prospects. Could you please introduce yourself…

Mexico The founder and Managing Director of Global Health Intelligence (GHI), Guillaume Corpart highlights the value of competitive intelligence for medical device companies looking to either enter emerging healthcare markets in Latin America and Asia or identify new market opportunities. As an introduction for our readers, Guillaume, could you elaborate on…